Dutch consumer electronics giant Philips Electronics NV (PHGFF.PK, PHG) reported Monday that its fourth-quarter income from operations was 24 million euros, including charges of 363 million euros connected with the Respironics consent decree, which has been agreed with the US Department of Justice or DOJ, representing the US Food and Drug Administration.
Executives from Philips, Basemed Kare Inc., and Elekta, during the contract signing agreement, February 26, 2022. (From left) Basemed Kare Inc. Director Karl Zapanta; Philips Sales and Clinical Modality Head Seneriza Castro; Basemed Kare Inc. President Bernadette Zapanta, Basemed Kare Director Chris